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Ependymomas are tumours that arise throughout the central nervous system. Little is known regarding the aberrant cellular and
molecular processes that generate these tumours. This lack of knowledge has hampered efforts to reduce the significant mortality and
morbidity that are associated with ependymoma. Here, we review recent data that suggest that radial glia are cells of origin of
ependymoma, and discuss the processes that might transform these neural progenitors into ependymoma cancer stem cells.
British Journal of Cancer (2007) 96, 6–10. doi:10.1038/sj.bjc.6603519 www.bjcancer.com
Published online 19 December 2006
& 2007 Cancer Research UK
Keywords: stem cell; ependymoma; brain; tumour; CD133 radial glia
                              
Ependymomas are central nervous system (CNS) tumours that
originate from the wall of the ventricular system along the entire
craniospinal axis (Kleihues et al, 2002). Although ependymomas
from different regions of the CNS are histologically similar, they
are clinically (Moynihan, 2003) and genetically (Ebert et al, 1999;
Dyer et al, 2002; Taylor et al, 2005) distinct, suggesting that they
represent a collection of different diseases. Intracranial ependy-
momas often recur at the primary tumour site and less than 60%
of children with this disease will survive more than 5 years (Gatta
et al, 2002). Despite this significant clinical burden, we have
learned almost nothing new about the biology and treatment of
ependymoma during the last 20 years. Indeed, less than 5% of the
14200 brain tumour research studies published in the last 5 years
have investigated ependymoma. Unless we can increase under-
standing of the biology of ependymoma we are unlikely to reduce
the morbidity and mortality associated with this disease.
CANCER STEM CELLS
Cancer researchers have invested a great deal of effort in
characterising the genetic alterations that accumulate in end-stage
tumours. Although these studies can provide lists of the genetic
events that contribute to the expansion of malignant clones, they
do not inform us regarding the chronology or relative importance
of each of these alterations in the cancer process. A more
comprehensive understanding of cancer that spans the life of the
disease from the birth of the first malignant cell to clinical
presentation, would be invaluable in the hunt for more effective
treatments of cancer. With this in mind, considerable excitement
has surrounded the recent discovery of cancer stem cells (CSC)
(Clarke and Fuller, 2006). Cancer stem cell make up just a small
fraction of the total population of the malignant cells in many solid
tumours and leukaemias. However, evidence indicates that these
self-renewing and multipotent stem cell-like cells generate all of
the phenotypically diverse cells that populate tumours (Lapidot
et al, 1994; Bonnet and Dick, 1997; Al-Hajj et al, 2003; Singh et al,
2004; Taylor et al, 2005). The discovery of CSC has therefore
provided researchers with a practical point of focus for studying
the natal cellular and molecular events of tumorigenesis.
The identification of CSC is likely to have important implica-
tions for the treatment of cancer. If tumours are derived entirely
from CSC, then it would follow that to be curative, cancer
treatments should disable or destroy these cells. Indeed, drugs that
are designed to kill CSC could prove highly effective treatments
of cancer. On the other hand, evidence that CSCs are remarkably
similar to normal stem cells predict that such treatments may also
possess significant toxicities. For example, brain CSC express the
neural stem cell markers Nestin and CD133 (Hemmati et al, 2003;
Galli et al, 2004; Singh et al, 2004; Taylor et al, 2005), whereas
acute myeloid leukaemic CSC display the CD34
þ/CD38
  immuno-
phenotype of haematopoietic stem cells (HSC) (Lapidot et al, 1994;
Bonnet and Dick, 1997). Thus, the development of safe and
effective therapies for all cancers is likely to require understanding
of the similarities and differences between normal and malignant
stem cells in tissues.
RADIAL GLIA ARE CANDIDATE CELLS OF ORIGIN OF
EPENDYMOMA CSC
Comparative studies of normal and malignant HSC have been
facilitated by the availability of robust assays for all stages of
haematopoiesis (Warner et al, 2004). In contrast, knowledge of the
stem and progenitor cell populations of non-haematologic organs
is limited. Therefore, identifying the cell of origin of solid tumour
CSC and the molecular alterations that transform these cells is less
straight forward. Recently, we compared the gene expression
profiles of developing tissues and ependymoma subsets to identify
populations of cells in the CNS which act as the cells of origin of
ependymomas (Taylor et al, 2005).
In an analysis of over 100 ependymomas, we found that tumour
subsets exhibit distinct patterns of gene expression and regions
of chromosome gain and loss that correlate with the anatomic
location of the tumour (supratentorial region, posterior fossa or
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discriminated supratentorial, posterior fossa and spinal ependy-
moma included many genes that are known regulators of neural
precursor cells in the corresponding region of the CNS. For
example, we found that supratentorial tumours express markedly
elevated levels of members of the EPHB-EPHRIN and NOTCH cell
signal systems that play key roles in maintaining normal neural
stem cells in the cerebral subventricular zone (SVZ) (Conover et al,
2000; Hitoshi et al, 2002). Conversely, spinal ependymomas
expressed multiple Homeobox (HOX) family members that
coordinate antero-posterior tissue patterning and development of
the spine (Dasen et al, 2003; Kmita and Duboule, 2003). Therefore,
we reasoned that subsets of ependymoma either maintain, or
recapitulate the developmental expression profiles of anatomically
restricted progenitor cells. To identify these precursor cells in the
normal CNS, we used in situ hybridisation and immunofluores-
cence to map the site of expression of ependymoma signature
genes in the developing mouse. These data identified remarkable
similarities between the distinct gene expression patterns observed
in embryonic radial glia (RG) – that are neural progenitor cells
(see below) – and those observed in human ependymomas from
the corresponding region of the CNS. The great majority of
intracranial tumours in our study arose in children; whereas the
spinal tumours were obtained from adult patients. Therefore, our
data suggest that RG are a likely source of ependymomas
independent of patient age. It is noteworthy that astroglial cells
with functional and molecular characteristics of RG persist in the
SVZ of the lateral ventricles and possibly the spinal cord,
suggesting that some RG give rise to adult neural stem cells
(Merkle et al, 2004; Barry and McDermott, 2005). It is possible
that these RG-derived stem cells are cells of origin of adult
ependymomas. We are conducting extensive genomic and func-
tional studies of stem cell populations in normal and malignant
embryonic and adult neural tissues to identify the precise cell of
origin of each type of ependymoma.
Importantly, we showed also that self-renewing and multipotent
CSC isolated from fresh samples of ependymoma are: bipolar
RG-like cells; express the CD133þ/Nestinþ/RC2þ/brain lipid-
binding protein (BLBP)þ immunophenotype of RG; and are both
required and sufficient to generate tumours in vivo. Our data
suggest a new hypothesis for the origin of ependymoma: that RG in
different parts of the CNS are predisposed to acquire distinct
genetic abnormalities that transform these cells into CSC of
supratentorial, posterior fossa and spinal ependymoma.
WHAT ABERRANT PROCESSES TURN RG INTO CSC?
To determine whether ependymoma CSC arise from RG, and how
this malignant transformation may occur, it is important to
understand the processes that regulate the generation and fate of
RG in the CNS. In vertebrates, neural stem cells first appear as a
layer of pseudostratified epithelium that lines the neural plate and
neural tube before the onset of neurogenesis. These neuroepithelial
cells (NEC) are highly polarised along their apical–basal axis (Gotz
and Huttner, 2005). Of particular note, the apical cell membrane of
NEC contains characteristic transmembrane proteins, for example,
prominin-1 (the mouse orthologue of human CD133), and adjacent
adherens junctions that are thought to regulate cell proliferation
and fate decisions.
As neurogenesis begins, NEC give rise to RG. RG retain the
highly polarised features of NEC and express CD133, Nestin and
RC2, but they also express astrocyte-specific proteins that include
glutamate transporter and BLBP (Kriegstein and Gotz, 2003).
Previously, RG were believed to generate only astroglial cells.
However, studies conducted within the last 5 years indicate that
RG are mitotically active, multipotent progenitor cells that
probably give rise to the majority of neurons, astrocytes,
oligodendrocytes and ependymal cells in the brain (Fishell and
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Figure 1 Symmetric and asymmetric division of NEC and RG. Neuroepithelial cell and RG (green) are highly polarised. The apical membrane (blue) is
flanked by adherens junctions (red ovals) that are thought to transduce pro-proliferative signals and determine daughter cell fate. EMX2 promotes symmetric
division (in embryonic stem cells) that distributes the apical membrane equally to the two daughter cells, resulting in stem cell proliferation. Both Emx2 (in
adult neural stem cells) and Pax6 can promote asymmetric division. Only the daughter cell that inherits the apical membrane resembles the mother cell, the
remaining daughter is fated to differentiate (blue, e.g. neuron).
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symmetric and asymmetric cell division (Figure 1). Symmetric
division expands the neural stem and progenitor cell pool, as this
generates two identical daughter cells that resemble the parent
NEC or RG cell. In contrast, asymmetric divisions generate
unequal daughter cells: one stem cell and one cell that is fated to
differentiate. In normal tissues, stem cell self-renewal – cycles of
division that repeatedly generate at least one daughter equivalent
to the mother cell – is tightly regulated, and deregulation of this
process is emerging as a key event in the development of CSC
(Clarke and Fuller, 2006). Thus, if ependymoma CSC arise from
RG, then the factors that coordinate RG cell division might
represent targets for mutations that underlie the initiation of this
brain tumour.
Aberrant RG cleavage
The apical plasma membrane appears to play an important role in
determining the fate of NEC and RG daughter cells (Gotz and
Huttner, 2005). Daughter cells that inherit the apical membrane
retain the proliferative stem cell properties of the parent cell
(Figure 1). Thus, it has been suggested that the apical membrane
acts as a transducer of pro-proliferative signals from the neural
tube to NEC and RG (Gotz and Huttner, 2005). Indeed, equal
distribution of the apical membrane between the progeny of
symmetrically dividing RG, might explain why this division results
in identical daughter cells with proliferative progenitor cell
properties. Whether RG undergo symmetric or asymmetric
division appears to be controlled, at least in part, by certain
transcription factors (Figure 1). For example, Emx2 induces
symmetric divisions that can lead to expansion of RG cell
numbers, whereas Pax6 activates neurogenic, asymmetric division
(Heins et al, 2001, 2002). Interestingly, we found that expression of
EMX2, but not PAX6, is markedly upregulated in supratentorial
ependymomas compared to ependymomas from other regions of
the CNS (37-fold expression difference Po0.0001; Taylor et al,
2005). Thus, aberrant and prolonged expression of EMX2 within
embyonic cortical RG might contribute to increased symmetric cell
division and the formation of CSC of pediatric supratentorial
ependymoma (Figure 2). One important caveat against these rather
simple models of tumourigenesis, is the capacity of genes to confer
context dependent effects on stem cells. For example, studies have
shown that Emx2 can operate as a negative regulator of symmetric
cell division in adult neural stem cells (Galli et al, 2002). Better
understanding of the precise cell of origin of ependymomas should
help to clarify the role of specific genes in the development of these
diseases.
Disruption of RG adherens junctions
Neuroepithelial cell and RG each contain concentrations of
adherens junctions that are located immediately beneath the
apical plasma membrane (Gotz and Huttner, 2005). Evidence
indicates that disruption of these complexes could also contribute
to the transformation of RG (Figure 2). Indeed, deletion of the
essential adherens gene aE-Catenin from neural progenitor cells in
mice results in severe disruption of the apical cell junctions, loss of
cell polarity, increased stem cell proliferation and the formation of
tumour-like masses in the brain (Lien et al, 2006). It remains to be
determined whether disruption of adherens complexes, that occurs
frequently in human cancers, might contribute to the formation of
CSC in the brain (Cavallaro and Christofori, 2004).
Deregulation of cell signal pathways
Certain cell signal pathways that control RG self-renewal are
deregulated in ependymoma. Most notable among these is the
NOTCH cell signal pathway. Upregulation of the Notch ligand
Jagged1 maintains the self-renewal and multipotency of adult
neural stem cells, whereas deletion of Notch1 depletes the neural
stem cell fraction (Hitoshi et al, 2002; Nyfeler et al, 2005). Further,
retroviral transfer of activated Notch1 into cells lining the SVZ
of the forebrain of embryonic mice promotes the formation and
maintenance of RG (Gaiano et al, 2000). Interestingly, the Notch
cell signal pathway might serve as a link between the symmetry of
NEC and RG division and the fate of daughter cells. In this regard,
deletion of Lethal Giant Lavae-1 from dividing neural stem cells
of mice, prevents the asymmetric localisation the Notch inhibitor
Numb to daughter cells, resulting in failure of asymmetric cell
divisions and the formation of tumour-like masses within the
brain (Klezovitch et al, 2004). We found that the signature genes
that are most upregulated in supratentorial ependymomas include
the NOTCH ligands JAGGED 1 and 2, and the NOTCH signal
targets HES1 and HES5 (Taylor et al, 2005). Interestingly, the
ERBB2 oncogene that is expressed to high levels in ependymoma,
is an important target of Notch signalling in RG (Gilbertson et al,
2002; Ever and Gaiano, 2005). Downregulation of ErbB2 expression
or activity in RG causes these cells to differentiate, whereas
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Figure 2 Potential mechanisms of RG transformation. Aberrant RG
cleavage mediated by certain transcription factors, disruption of adherens
junctions and deregulation of pro-proliferative cell signals could each
accelerate RG self-renewal and expansion of the stem cell pool. In
cooperation with additional mutations these events might result in the
generation of CSC.
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Ink4a that are encoded by the Ink4a/Arf locus, are
two additional regulators of neural stem cell proliferation. In this
regard, Bmi1 promotes the self-renewal of neural stem cells by
repressing transcription at the Ink4a/arf locus; whereas deletion of
Ink4a significantly expands the neural progenitor cell population
(Bruggeman et al, 2005; Molofsky et al, 2005). We found that
concurrent activation of NOTCH cell signalling and deletion of
INK4A/ARF affect the great majority of supratentorial ependymo-
mas. Specifically, using array comparative genomic hybridisation
and fluorescence in situ hybridisation, we have shown that INK4A/
ARF is selectively deleted from 490% of tumour cell nuclei of
supratentorial ependymomas but is rarely deleted from tumours
arising in other regions of the CNS (Taylor et al, 2005). Thus,
cortical RG might be susceptible to transformation into ependy-
moma CSC by concurrent activation of NOTCH signalling and
deletion of INK4A/ARF.
Further studies will be required to characterise fully the factors
that contribute to the formation of ependymoma CSC. These
efforts are likely to be assisted by ongoing studies of flies that have
identified already tumour suppressor genes that regulate the
proliferation of neural stem cells. For example, the Drosophila
tumour suppressor protein Brat is normally distributed asymme-
trically to one of the daughters of dividing neural stem cells, fating
that cell to differentiate, whereas the remaining daughter cell self-
renews (Betschinger et al, 2006). In Drosophila brat mutants both
daughter cells self-renew, resulting in expansion of the stem cell
pool and the formation of larval brain tumours.
EPENDYMOMA CSC AND THE CLINIC
If the CSC hypothesis proves correct and brain tumours, including
ependymoma, arise from rare fractions of stem-like cancer cells,
then these findings will lead to a paradigm shift in the way we
treat CNS tumours. In particular, we should begin to develop
classification systems and targeted treatment strategies that focus
on the eradication of CSC. This strategy may prove particularly
effective in tumours such as ependymoma that include develop-
mentally and molecularly distinct subgroups that are unlikely to
respond uniformly to all treatments.
At least two approaches might be adopted in the development of
anti-CSC therapies. First, as normal stem cells are protected from
environmental insults by both cell intrinsic and extrinsic factors,
then CSC might be inherently resistant to conventional chemo-
and radiotherapies (Dick and Lapidot, 2005). Thus, agents that
counteract CSC drug resistance mechanisms might prove useful in
the treatment of cancer. Second, targeting the pathways that
regulate aberrant self-renewal could be used to disable or destroy
CSC. Clinical trials of one such class of drugs, inhibitors of
g-secretase, are currently underway among patients with leukaemia,
and plans to trial these agents among children with ependymoma
are in advanced stages within the US Pediatric Brain Tumor
Consortium. NOTCH signalling is activated following g-secretase
mediated cleavage of the NOTCH receptor (Radtke and Raj, 2003).
Thus, inhibitors of g-secretase might be effective treatments of
supratentorial ependymomas.
The success of anti-CSC therapies will require not only that
these drugs kill or disable CSC, but also that they spare normal
stem cells. This issue is especially important when considering the
treatment of children with brain tumours whose nervous system is
still developing. Thus understanding further the origins of CSC in
the brain and how best to target these in the clinic will likely
require the ongoing collaboration of developmental biologists,
cancer biologists and clinicians.
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